Global Health (MEDANTA) Q4 25/26 earnings summary

Executive summary

• Achieved strong operational and financial performance in FY 2026, with 20% revenue and 15.1% PAT growth, driven by patient volume growth, improved realizations, and capacity expansion.

• Added 623 beds, including new facilities in Noida, Patna, Ranchi, and expanded clinical talent with 550+ new doctors.

• Opened a 550-bed Noida hospital, acquired land for a 400+ bed hospital in Guwahati, announced a 400-bed project in Varanasi, and expanded in Indore with a 280-bed acquisition.

• Mature hospitals delivered steady 9% revenue growth, while developing hospitals showed strong momentum with 29% revenue and 35% EBITDA growth.

• Audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, were approved with unmodified audit opinions.

Financial highlights

• FY2026 total income grew 20% year-on-year to INR 45,089 million; EBITDA (ex-Noida) rose 19% to INR 11,343 million (25.7% margin); consolidated PAT increased 15.1% to INR 5,541 million.

• Q4 FY2026 revenue reached INR 11,958 million, up 25% year-on-year; EBITDA (ex-Noida) up 27% to INR 3,142 million.

• Standalone revenue for FY26 was Rs. 37,093.78 million; consolidated revenue was Rs. 44,102.66 million.

• International business revenue grew 33% year-on-year to INR 2,780 million.

• Final dividend of INR 0.50 per share recommended, subject to shareholder approval.

Outlook and guidance

• Noida hospital expected to break even in the second half of FY 2027 as occupancy ramps up.

• Over INR 45,000 million capex planned for the next five years, targeting expansions in Delhi, Mumbai, Guwahati, and Varanasi.

• FY 2027 CapEx expected at INR 8–9 billion; FY 2028 at INR 6–7 billion.

• Focus on sustainable growth through bed additions, new specialties, and digital health initiatives.

• The company continues to monitor regulatory changes, especially regarding new Labour Codes.